Page 10 - Pharmaceutical

Launch of inhalation product improves Lupin's revenue visibility

More US launches and uptick in the Indian market are key near-term triggers

Lupin gets USFDA approval for asthmatic symptoms prevention drug

Drug major Lupin on Tuesday said it has received approval from the US health regulator for its Albuterol Sulfate Inhalation Aerosol, used for treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms. The approved product is a generic version of ProAir HFA of Teva Branded Pharmaceutical Products R&D, Inc. In a regulatory filing, Lupin said it has received approval from the United States Food and Drug Administration (USFDA) for its Albuterol Sulfate Inhalation Aerosol, 90 mcg (base)/actuation. Vinita Gupta, CEO, Lupin said: "The approval is timely as Albuterol MDI is a key rescue inhalation product for asthma patients who are at an increased risk of COVID-19-related complications. We look forward to launching the product this quarter and expect a steady ramp-up through the fiscal year. Quoting IQVIA moving annual total June 2020 data, Lupin said the total Albuterol Sulfate Inhalation Aerosol market had US sales of approximately USD 2.9 billion, of which the ...

API segment supports growth for large generic pharma players in Q1

However, price correction could lead to growth moderation in the near term

Hunting down the counterfeit menace: A novel app to identify spurious goods

Ennoventure has designed a novel app to identify spurious goods

India's pharma market to grow by 12-14% in three years, says KPMG

India's domestic pharmaceuticals market is expected to grow by 12% to 14% in the next three years while the export market may grow by 8% to 14%

French group Sanofi to buy US firm Principia Biopharma for $3.7 billion

PARIS (Reuters) - French healthcare company Sanofi SA has agreed to buy U.S. company Principia Biopharma Inc for around $3.7 billion, the companies said on Monday, strengthening Sanofi's presence in research and development (R&D) areas.

AstraZeneca says could begin Covid-19 vaccine production early in 2021

AstraZeneca Mexico's head said that Phase III trials were expected to conclude by November or December

Companies to now test drugs that deliver antibodies to fight Covid-19

The experimental drugs shortcut the process of antibody formation by giving concentrated versions of specific ones that worked best against the coronavirus in tests

Dr Reddy's Laboratories launches drug to treat infections in US market

Ciprodexis used in adults and children 6 months of age or older to treat certain types of infections caused by certain germs called bacteria

Donald Trump signs 'buy American first' pharmaceutical executive order

US President Donald Trump has signed an executive order directing some federal agencies to prioritise purchasing certain drugs and medical materials when made in the United States

Hetero joins long list of firms to launch Covid-19 drug favipiravir

Will sell its oral anitiviral for Rs 59 a pill, Cipla and DRL to launch soon

Glenmark cuts price of Covid drug FabiFlu by 27% within a month of launch

Higher yields and better scale allowed a price cut, said Company

Strides Pharma gets DGCI approval to test potential Covid-19 drug

Glenmark was the first Indian firm to get approval from regulator to conduct trials on Favipiravir tablets, which are otherwise used to treat influenza

Inovio says COVID-19 vaccine produces antibodies in mice, guinea pigs

The company's shares, which have more than quadrupled this year, surged 17.7% to $17.13 in trading before the bell

GST rates and the medical devices industry

Let us use the GST rate regime to build up a strong domestic industry in sectors like pharmaceuticals and medical devices that can play to our strengths in labour-intensive production

Covid-19 throws up drug supply opportunity for Ipca, other pharma firms

Sun Pharma, Dr Reddy's, Torrent Pharma, Cipla, Cadila Healthcare and Natco Pharma would also benefit from malaria drug supplies, Alembic Pharma from azithromycin sales

Divi's Laboratories begins commercial production at Visakhapatnam unit

Divi's Laboratories, established in Hyderabad, is a pharmaceutical company with two manufacturing units

Laudable move by Pharmexcil

The Pharmexcil came up with clarifications for its members and representations to the government highlighting some difficulties

NPPA allows differential price for Meril's biodegradable cardiac stent

The National Pharmaceutical Pricing Authority (NPPA) invoked the para 32 (ii) of the Drug Price Control Order, 2013 to grant the exemption to the indigenously developed stent

Regulatory woes resurface for Indian pharma companies as stocks fall

Concerns over US sales are diluting positives of strong domestic growth, and have led to a 10 per cent fall in the Nifty Pharma index in one month